>> HOMEPAGE

Diabetes

Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus.

Ambrosch A; Dierkes J; Lobmann R; Kuhne W; Konig W; Luley C; Lehnert H

Diabet Med 2001 Mar;18(3):185-92

AIMS: Limited data are available on determinants of diabetic neuropathy as its pathogenesis is multifactorial. Since homocysteine exhibits toxic effects on vascular endothelial cells, the association between homocysteine and the prevalence of neuropathy in Type 2 diabetes mellitus was investigated. METHODS: A total of 65 Type 2 diabetic patients were consecutively enrolled into the study. Neuropathy was diagnosed according to clinical symptoms, clinical examination, electrophysiological sensory testing and autonomic function testing. With regard to homocysteine-related parameters, plasma homocysteine, folate, vitamin B12, vitamin B6 and renal function (creatinine, ceratinine clearance, cystatin C) were measured, and the C677T polymorphism of the methylenetetrahydrofolate reductase gene was determined. RESULTS: Forty-three of the Type 2 diabetic patients were classified as suffering from neuropathy. Both patient groups were comparable with regard to demographic data, blood pressure, glucose metabolism, renal function and homocysteine-related vitamins. In contrast, homocysteine levels (P = 0.04) and the frequency of hyperhomocysteinemia (>or= 15 micromol/l) (P = 0.01) were significantly increased in neuropathic patients. In a logistic regression model with neuropathy as dependent variable, homocysteine (adjusted for creatinine, homocysteine-related vitamins, HbA1c and duration of diabetes) was the only significant variable associated with the prevalence of neuropathy (odds ratio for homocysteine per 5 micromol/l increase: 2.60 (95% confidence interval 1.07-6.33)). CONCLUSION: The data indicate that homocysteine is independently associated with the prevalence of diabetic neuropathy in a collective of Type 2 diabetic patients. A larger, prospective study would be desirable to clarify the role of homocysteine in the pathogenesis of diabetic neuropathy.

Sitemap

Was ist neu:

Anfang vom Ende des Pharma-Kartells: Eine Industrie am Rande des völligen Niedergangs

Neue Studie bezieht potentiell tödliche Muskelerkrankung auf cholesterinsenkende Medikamente

Osteoporose natürlich vorbeugen und ohne Medikamente kontrollieren

Die dunkle Geschichte der Borreliose-Krankheit: Bezüge zur Biowaffen-Forschung

Der zellular-medizinsche Ansatz bei der Vorbeugung und Kontrolle häufiger Augenerkrankungen

Lehren aus der tödlichen Viagra-Studie an Schwangeren: Sichere, natürliche Alternativen sollten bei klinischen Versuchen Vorrang haben

Gates-Stiftung unterstützt Plan zur globalen „Harmonisierung von Nährstoffgrenzen“ in Ergänzungsmitteln

Natürliche Behandlung von Immunschwächekrankheiten

Die Geschichte des Pharma-Kartells

Mikronährstoffe können vor Zellschäden durch Strahlung schützen

» Natürliche Gesundheit

» "Geschäft m. d. Krankheit"

» Internationale Kampagne

» Dr. Raths Offene Briefe

» Studien weltweit

» Studien auf Deutsch

» Helfen Sie mit!

» Codex Alimentarius

» Dossiers

» Sitemap

Dr. Rath Health Foundation auf Facebook Dr. Rath Health Foundation auf YouTube Dr. Rath Health Foundation auf Twitter RSS
 © 2018 Dr. Rath Health Foundation | Kontakt | Impressum | Datenschutzerklärung | RSS Feed